Skip to content

Optimal Multimodal Analgesia in Abdominal Hysterectomy

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00209872
Enrollment
60
Registered
2005-09-21
Start date
2005-10-31
Completion date
Unknown
Last updated
2007-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Planned Abdominal Hysterectomy

Brief summary

The purpose of this study is to test the current standard of care (SOC) treatment for abdominal hysterectomy with a group receiving SOC minus epidural analgesia plus additional perioperative analgesics in terms of postoperative abilities, postoperative nausea and vomiting (PONV), pain and discharge time from the PACU (post-anaesthesia care unit).

Detailed description

Aim of the study: to compare postoperative complaints (PONV, pain, etc) and PACU discharge time between two groups, for patients admitted for planned abdominal hysterectomy with or without BSO: * A: standard of care (SOC) receiving paracetamol, celecoxib, epidural analgesia, dexamethasone, ondansetron and droperidol, and general anaesthesia with propofol, remifentanil and cisatracurium * B: SOC with sham epidural analgesia, preoperative gabapentin, intraoperative lidocaine, s-ketamine and sufentanil

Interventions

DRUGGabapentin
DRUGLidocaine
DRUGS-ketamine
PROCEDUREEpidural analgesia

Sponsors

Hvidovre University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Planned abdominal hysterectomy with or without BSO * Age above 18 years * Written informed consent * American Society of Anesthesiologists (ASA) class I-III

Exclusion criteria

* Planned vaginal or laparoscopic hysterectomy * Hysterectomy as part of other surgery * Allergy to part of the treatment regimen * Previous reactions to opioids (nausea, cognition) * Previous inability to place correct epidural catheter * Severe state anxiety according to the OCAP or STAI * ASA class IV * Dependency on alcohol, opioids or central stimulants * Chronic pain condition * Hemorrhagic diathesis * Participation in another study

Design outcomes

Primary

MeasureTime frame
Postoperative abilities over time
Discharge time from PACU according to fixed criteria
Consumption of analgesics and antiemetics in the PACU

Secondary

MeasureTime frame
Degree of nursing requirements at the PACU
General tolerability of the regimes
Threshold for sensory perception and pain using the Pain Matcher device, pre- and postoperatively

Countries

Denmark

Contacts

Primary ContactKenneth Jensen, M.D.
kenneth.jensen@hh.hosp.dk+45 36 32 62 90

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026